• The Bing-Neel syndrome is a rare clinicopathological entity which refers to central nervous system localization by lymphoplasmacytic lymphoma. • The treatment of Bing-Neel syndrome remains non‐standardized and further data about patient long‐term outcome is needed. • This case-report supports the evidence of effectiveness and safety of MaTrix regimen as induction therapy in Bing-Neel syndrome patients.
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy / Carella M.; Stefoni V.; Broccoli A.; Argnani L.; Zinzani P.L.. - In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - ISSN 2152-2650. - ELETTRONICO. - 21:11(2021), pp. e817-e819. [10.1016/j.clml.2021.06.017]
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy
Carella M.;Stefoni V.;Broccoli A.;Argnani L.;Zinzani P. L.
2021
Abstract
• The Bing-Neel syndrome is a rare clinicopathological entity which refers to central nervous system localization by lymphoplasmacytic lymphoma. • The treatment of Bing-Neel syndrome remains non‐standardized and further data about patient long‐term outcome is needed. • This case-report supports the evidence of effectiveness and safety of MaTrix regimen as induction therapy in Bing-Neel syndrome patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
